GO:0043048 dolichyl monophosphate biosynthetic process: Biosynthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043048 describes the chemical reactions and pathways that produce dolichyl monophosphate, a phosphorylated dolichol derivative that serves as the lipid carrier for N-linked glycosylation.
• Dolichyl monophosphate is synthesized in the endoplasmic reticulum and is essential for the assembly of the dolichol-linked oligosaccharide precursor in the N-linked glycosylation pathway.
• The pathway is conserved from yeast to humans and involves enzymes such as dolichyl pyrophosphate phosphatases and dolichol kinases that interconvert dolichol derivatives.
• Dolichyl monophosphate levels are tightly regulated because insufficient or excess dolichyl phosphate impairs protein glycosylation and endoplasmic reticulum homeostasis.
• Defects in dolichyl monophosphate metabolism are linked to congenital disorders of glycosylation and have been implicated in retinal and neurological pathologies.
• Research on GO:0043048 uses yeast and mammalian cell models, CRISPR knockout and point-mutation strategies, and biochemical assays to dissect enzyme function and pathway flux.
Description
Dolichyl monophosphate (Dol-P) is a phosphorylated dolichol derivative that functions as the membrane-bound lipid carrier for the assembly of the N-linked oligosaccharide precursor in the endoplasmic reticulum (ER). The biosynthetic process that generates Dol-P, annotated as GO:0043048 (dolichyl monophosphate biosynthetic process), encompasses the enzymatic steps that convert dolichol and related intermediates into dolichyl monophosphate. This process is a prerequisite for the dolichol pathway of N-linked glycosylation, which modifies nascent polypeptides and influences protein folding, stability, and trafficking. Because Dol-P is the obligate carrier for the stepwise addition of monosaccharides to the dolichol-linked oligosaccharide, its availability directly controls the flux of N-linked glycosylation. The pathway is conserved across eukaryotes, and studies in yeast have provided much of the mechanistic framework for understanding Dol-P biosynthesis and its regulation. In plants, dolichyl monophosphate and its sugar derivatives have also been characterized, indicating a broad evolutionary conservation of this lipid intermediate. For researchers, GO:0043048 is a focal point for understanding ER homeostasis, protein quality control, and the molecular basis of glycosylation disorders. The pathway intersects with dolichol recycling, dolichyl pyrophosphate phosphatase activities, and the regulation of dolichol kinase, making it a rich area for genetic and biochemical investigation. This article synthesizes the current understanding of GO:0043048, its enzymatic components, its regulation, and the experimental models used to study it.
dolichyl monophosphate biosynthetic process At A Glance
| GO ID | GO:0043048 |
|---|---|
| GO term | dolichyl monophosphate biosynthetic process |
| Ontology | biological_process |
| Synonym | dolichyl monophosphate anabolism; dolichyl monophosphate biosynthesis; dolichyl monophosphate formation; dolichyl monophosphate synthesis |
| Major function | Production of dolichyl monophosphate, the lipid carrier for N-linked glycosylation |
| Subcellular location | Endoplasmic reticulum membrane |
| Key enzymes | Dolichyl pyrophosphate phosphatases, dolichol kinases, and related dolichol metabolism enzymes |
| Related pathway | Dolichol pathway of N-linked glycosylation |
| Conservation | Conserved from yeast to humans and in plants |
What Is GO:0043048?
GO:0043048, dolichyl monophosphate biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of dolichyl monophosphate, a phosphorylated dolichol derivative. In practical terms, it covers the enzymatic steps that produce Dol-P, the lipid carrier required for N-linked glycosylation in the endoplasmic reticulum.
Why Is dolichyl monophosphate biosynthetic process Important in Cell Biology?
GO:0043048 is important because dolichyl monophosphate is the central lipid intermediate that enables the assembly of the dolichol-linked oligosaccharide precursor, a mandatory step for N-linked glycosylation of secretory and membrane proteins. Without adequate Dol-P, protein folding, trafficking, and cell-surface expression of glycoproteins are compromised, which affects development, immune function, and neuronal physiology. The pathway is also a point of vulnerability in congenital disorders of glycosylation and has been linked to retinal degeneration and brain dysfunction. Understanding how Dol-P is synthesized and regulated therefore provides mechanistic insight into ER biology and human disease.
• Dolichyl monophosphate is the obligate lipid carrier for N-linked glycosylation, a fundamental protein modification in eukaryotes.
• The pathway is conserved from yeast to humans, making model organisms informative for human biology.
• Dol-P biosynthesis is required for embryonic development and glycoprotein synthesis in early embryogenesis.
• Dolichyl phosphate recycling and biosynthesis are coordinated in the ER to maintain glycosylation flux.
• Dolichyl monophosphate and its sugar derivatives are present in plants, indicating broad biological significance.
• Enzymes such as dolichyl pyrophosphate phosphatase regulate the balance between dolichol and dolichyl monophosphate.
• The retina relies on the dolichol pathway for rhodopsin glycosylation, linking Dol-P to visual function.
• Dolichol-phosphate mannose synthase connects Dol-P metabolism to glycosylphosphatidylinositol anchor and O-mannosylation pathways.
• Defects in dolichol metabolism can cause congenital disorders of glycosylation and neurological disease.
• CRISPR-based models of Dol-P biosynthetic genes enable causal testing of gene function in glycosylation and disease.
What Happens During dolichyl monophosphate biosynthetic process?
Formation of dolichyl monophosphate from dolichol and dolichyl pyrophosphate
In simple terms: The cell makes dolichyl monophosphate by adding or removing phosphate groups on dolichol molecules.
Dolichyl monophosphate is generated through enzymatic reactions that interconvert dolichol, dolichyl monophosphate, and dolichyl pyrophosphate. Dolichyl pyrophosphate phosphatase activities can dephosphorylate dolichyl pyrophosphate to yield dolichyl monophosphate, and dolichol kinase can phosphorylate dolichol to form Dol-P. These reactions occur in the endoplasmic reticulum membrane and maintain the pool of Dol-P available for glycosylation.
Role of dolichyl monophosphate in the dolichol cycle
In simple terms: Dolichyl monophosphate acts as a shuttle that carries sugars onto proteins.
In the dolichol pathway of N-linked glycosylation, Dol-P accepts monosaccharides from nucleotide sugars to form dolichyl monophosphate sugars, which then donate sugars to the growing oligosaccharide on the lipid carrier. After the oligosaccharide is transferred to protein, the dolichol carrier is recycled back to Dol-P through dephosphorylation and rephosphorylation steps. This cycle ensures a continuous supply of Dol-P for glycoprotein biosynthesis.
Subcellular site and membrane topology
In simple terms: This process happens on the membrane of the endoplasmic reticulum, the cell's protein factory.
The biosynthesis of dolichyl monophosphate is localized to the endoplasmic reticulum membrane, where dolichol and its phosphorylated derivatives are embedded. The enzymes that synthesize and recycle Dol-P are integral membrane proteins whose active sites face the cytosol or the ER lumen, depending on the step. This topology allows Dol-P to participate in the vectorial assembly of the oligosaccharide precursor.
Regulation of dolichyl monophosphate levels
In simple terms: The cell adjusts how much dolichyl monophosphate it makes to match the demand for protein glycosylation.
Dolichyl monophosphate levels are regulated by the opposing activities of dolichol kinase and dolichyl pyrophosphate phosphatases, as well as by feedback from the glycosylation machinery. The pathway is also influenced by the availability of dolichol and by ER stress responses that alter lipid metabolism. Studies in yeast and mammalian cells have shown that perturbations in Dol-P synthesis affect the efficiency of N-linked glycosylation and protein folding.
Key Genes Involved in GO:0043048 dolichyl monophosphate biosynthetic process
The following genes and proteins are experimentally implicated in dolichyl monophosphate biosynthesis, its regulation, or its downstream use in glycosylation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DOLK | Dolichol kinase that phosphorylates dolichol to dolichyl monophosphate | Rate-limiting enzyme for Dol-P supply; mutations cause congenital disorders of glycosylation |
| DOLPP1 | Dolichyl pyrophosphate phosphatase that generates dolichyl monophosphate | Regulates Dol-P recycling and glycosylation flux |
| DPM1 | Dolichol-phosphate mannose synthase subunit | Uses Dol-P to synthesize dolichyl phosphate mannose for GPI anchors and O-mannosylation |
| DPM2 | Dolichol-phosphate mannose synthase regulatory subunit | Modulates DPM1 activity and Dol-P utilization |
| DPM3 | Dolichol-phosphate mannose synthase subunit | Stabilizes the DPM complex and links to glycosylation disorders |
| ALG5 | Dolichyl-phosphate beta-glucosyltransferase | Transfers glucose from UDP-glucose to Dol-P in the dolichol pathway |
| ALG7 | UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase | First step of dolichol-linked oligosaccharide assembly using Dol-P |
| RFT1 | Flipase for dolichol-linked oligosaccharide | Translocates the Dol-P-linked glycan across the ER membrane |
| OST1 | Oligosaccharyltransferase subunit | Transfers the oligosaccharide from Dol-P to nascent proteins |
| OST2 | Oligosaccharyltransferase subunit | Required for efficient N-linked glycosylation |
| SEC59 | Yeast dolichol kinase | Model enzyme for Dol-P biosynthesis studies |
| CWH8 | Yeast dolichyl pyrophosphate phosphatase | Regulates Dol-P recycling in yeast |
| PGM1 | Phosphoglucomutase 1 | Indirectly affects Dol-P sugar donor pools |
| MPDU1 | Dolichyl phosphate mannose synthase cofactor | Links Dol-P metabolism to glycosylation and disease |
| DDOST | Oligosaccharyltransferase subunit | Couples Dol-P-derived glycan to protein substrates |
| MAGT1 | Magnesium transporter and OST subunit | Supports oligosaccharyltransferase function and glycosylation |
| TUSC3 | Oligosaccharyltransferase subunit | Modulates N-linked glycosylation in development |
How Is dolichyl monophosphate biosynthetic process Regulated?
The biosynthesis of dolichyl monophosphate is regulated at multiple levels. The opposing enzymatic activities of dolichol kinase and dolichyl pyrophosphate phosphatases control the steady-state level of Dol-P in the endoplasmic reticulum membrane. Feedback from the N-linked glycosylation pathway and the availability of dolichol precursors also influence Dol-P synthesis, ensuring that the lipid carrier pool matches the demand for glycoprotein production. In yeast, genetic studies have identified regulatory interactions between Dol-P metabolism and the secretory pathway, and in mammalian cells, ER stress and lipid metabolic signals can alter Dol-P levels. Additionally, dolichol-phosphate mannose synthase activity is regulated by its subunits and by the supply of GDP-mannose, linking Dol-P utilization to broader metabolic states.
dolichyl monophosphate biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DOLK | Congenital disorder of glycosylation with cardiac and neurological involvement | CRISPR knockout in HEK293 or iPSC-derived cardiomyocytes |
| DOLPP1 | Congenital disorder of glycosylation with liver and neurological symptoms | Knockout in HepG2 or patient fibroblasts |
| DPM1 | Congenital disorder of glycosylation with seizures and developmental delay | Point-mutation knock-in in yeast or human cell lines |
| DPM3 | Muscular dystrophy-dystroglycanopathy | CRISPR knockout in muscle cell lines |
| MPDU1 | Congenital disorder of glycosylation with skin and neurological features | Knockout in keratinocytes or fibroblasts |
Congenital disorders of glycosylation
Defects in dolichyl monophosphate biosynthesis and recycling cause congenital disorders of glycosylation (CDG), a group of inherited diseases characterized by defective protein glycosylation. Mutations in genes such as DOLK and DOLPP1 impair Dol-P production or recycling, leading to multisystem symptoms including neurological impairment, coagulopathy, and developmental delay. These disorders highlight the critical role of GO:0043048 in human health.
Retinal degeneration and rhodopsin glycosylation
The retina has a high demand for the dolichol pathway because rhodopsin, the visual pigment, is heavily glycosylated. Disruption of dolichyl monophosphate metabolism in the retina can impair rhodopsin glycosylation and contribute to retinal degeneration. This tissue-specific vulnerability underscores the importance of Dol-P biosynthesis for sensory function.
Neurological and developmental disorders
Dolichol metabolism is essential for brain development, and defects in Dol-P biosynthesis have been associated with neurological phenotypes such as seizures, hypotonia, and cognitive impairment. The brain's reliance on glycosylated proteins for synaptic function and myelination makes it particularly sensitive to perturbations in GO:0043048.
From dolichyl monophosphate biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DOLK impair dolichyl monophosphate synthesis? | CRISPR knockout of DOLK in HEK293 cells |
| Does a patient-specific point mutation in DOLPP1 alter enzyme activity? | Point-mutation knock-in in yeast or human cells |
| Can wild-type DOLK rescue glycosylation defects? | Knock-in of tagged DOLK for rescue and localization |
| How does DPM1 overexpression affect Dol-P utilization? | Overexpression of DPM1 in mammalian cells |
| Which genes buffer Dol-P deficiency? | CRISPR library screening in Dol-P-deficient cells |
| Does Dol-P loss affect rhodopsin glycosylation? | CRISPR knockout in retinal pigment epithelial cells |
How to Study the dolichyl monophosphate biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metabolic labeling with 3H-mannose | Dolichyl monophosphate sugar formation | Assessing Dol-P-dependent glycosylation flux |
| Thin-layer chromatography | Dolichol and Dol-P species | Quantifying lipid intermediates |
| Mass spectrometry | Dolichyl monophosphate molecular species | Structural characterization of Dol-P |
| Enzymatic phosphatase assay | Dolichyl pyrophosphate phosphatase activity | Testing DOLPP1 function |
| Lectin blotting | N-linked glycosylation status | Detecting glycosylation defects in KO cells |
| RNA sequencing | Transcriptional changes | Identifying ER stress and compensatory pathways |
| Proteomics | Protein abundance and glycosylation | Mapping Dol-P-dependent proteome |
| Fluorescence microscopy | Subcellular localization of enzymes | Validating ER localization of Dol-P enzymes |
Biochemical assays for dolichyl monophosphate
Dolichyl monophosphate levels can be measured using metabolic labeling with radioactive precursors, thin-layer chromatography, and mass spectrometry. Enzymatic assays for dolichol kinase and dolichyl pyrophosphate phosphatase activities provide direct readouts of the biosynthetic and recycling steps. These methods are essential for validating genetic models of GO:0043048.
Glycosylation profiling
Because Dol-P is required for N-linked glycosylation, changes in GO:0043048 can be assessed by analyzing glycoprotein profiles using lectin blotting, PNGase F treatment, and mass spectrometry of N-glycans. Yeast and mammalian cells with mutations in Dol-P biosynthetic genes show characteristic glycosylation defects that can be quantified.
Transcriptomics and proteomics
RNA sequencing and quantitative proteomics can reveal how loss of Dol-P biosynthesis affects gene expression, ER stress responses, and the abundance of glycosylated proteins. These approaches help identify compensatory pathways and disease-relevant networks linked to GO:0043048.
Imaging and subcellular localization
Fluorescence microscopy of tagged Dol-P biosynthetic enzymes and lipid probes can determine their subcellular localization and dynamics in the endoplasmic reticulum. Imaging of glycosylation reporters can also reveal cell-to-cell variability in Dol-P-dependent processes.
How CRISPR Can Be Used to Study GO:0043048 dolichyl monophosphate biosynthetic process
Knockout
CRISPR knockout of genes such as DOLK, DOLPP1, or DPM1 in human cell lines provides a direct way to test their requirement for dolichyl monophosphate biosynthesis. Knockout cells can be analyzed for Dol-P levels, glycosylation defects, and ER stress, establishing causal links between gene function and GO:0043048.
Point Mutation
Point-mutation knock-in using CRISPR can model patient-specific missense mutations in Dol-P biosynthetic enzymes, such as those found in congenital disorders of glycosylation. These models allow researchers to distinguish loss-of-function from hypomorphic alleles and to test enzyme activity in a physiological context.
Knock-in
Tagged knock-in of endogenous DOLK or DOLPP1 with fluorescent or affinity tags enables localization, interaction, and rescue studies without overexpression artifacts. Knock-in of wild-type alleles can also confirm that observed phenotypes are due to the targeted gene.
Overexpression
CRISPR-mediated overexpression or cDNA-based overexpression of Dol-P biosynthetic enzymes can increase Dol-P levels and test whether glycosylation capacity is enhanced. Overexpression models are useful for structure-function studies and for identifying rate-limiting steps in GO:0043048.
How EDITGENE Supports dolichyl monophosphate biosynthetic process Research
Researchers studying dolichyl monophosphate biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in Dol-P production, glycosylation, or disease. EDITGENE provides CRISPR-based cell models and screening services to accelerate this functional validation.
Contact EDITGENE today to design your custom CRISPR model for dolichyl monophosphate biosynthetic process research.
Frequently Asked Questions About dolichyl monophosphate biosynthetic process
What is dolichyl monophosphate biosynthetic process?
It is the biological process defined by GO:0043048 that produces dolichyl monophosphate, a phosphorylated dolichol derivative used as a lipid carrier in N-linked glycosylation.
What genes are involved in dolichyl monophosphate biosynthetic process?
Key genes include DOLK, DOLPP1, DPM1, DPM2, DPM3, ALG5, ALG7, and RFT1, which encode enzymes that synthesize or utilize dolichyl monophosphate.
Where does dolichyl monophosphate biosynthesis occur?
It occurs in the endoplasmic reticulum membrane, where dolichol and its phosphorylated derivatives are embedded.
Why is dolichyl monophosphate important for protein glycosylation?
Dolichyl monophosphate serves as the lipid carrier that accepts monosaccharides and donates them to the growing oligosaccharide precursor in N-linked glycosylation.
What diseases are linked to dolichyl monophosphate biosynthesis?
Defects in this pathway cause congenital disorders of glycosylation and have been associated with retinal degeneration and neurological impairment.
How is dolichyl monophosphate regulated?
It is regulated by the opposing activities of dolichol kinase and dolichyl pyrophosphate phosphatases, as well as by feedback from glycosylation demand.
What model organisms are used to study dolichyl monophosphate biosynthesis?
Yeast is a major model because the dolichol pathway is conserved and genetically tractable; mammalian cell lines and plants are also used.
What methods measure dolichyl monophosphate levels?
Metabolic labeling, thin-layer chromatography, mass spectrometry, and enzymatic assays are commonly used to quantify Dol-P and related lipids.
Can CRISPR be used to study dolichyl monophosphate biosynthetic process?
Yes, CRISPR knockout, point-mutation knock-in, and overexpression models enable causal testing of genes involved in Dol-P biosynthesis.
What is the GO ID for dolichyl monophosphate biosynthetic process?
The GO ID is GO:0043048, under the biological_process ontology.
Conclusion
GO:0043048, dolichyl monophosphate biosynthetic process, is a conserved and essential biological process that supplies the lipid carrier for N-linked glycosylation. Its enzymatic steps, regulation, and disease connections make it a compelling area for genetic and biochemical research. CRISPR-based models and multi-omics approaches now allow precise interrogation of this pathway in health and disease. Understanding Dol-P biosynthesis will continue to illuminate fundamental ER biology and inform therapeutic strategies for glycosylation disorders.
References
- 1. Burda P et al.. 1999. The dolichol pathway of N-linked glycosylation.. Biochim Biophys Acta 1426(2):239-57 PMID: 9878760
- 2. Lennarz WJ. 1983. Glycoprotein synthesis and embryonic development.. CRC Crit Rev Biochem 14(4):257-72 PMID: 6357632
- 3. Maeda Y et al.. 2008. Dolichol-phosphate mannose synthase: structure, function and regulation.. Biochim Biophys Acta 1780(6):861-8 PMID: 18387370
- 4. Knauer R et al.. 1999. The oligosaccharyltransferase complex from yeast.. Biochim Biophys Acta 1426(2):259-73 PMID: 9878773
- 5. Brett CT et al.. 1977. Dolichyl monophosphate and its sugar derivatives in plants.. Biochem J 161(1):93-101 PMID: 557975
- 6. Schenk B et al.. 2001. The ins(ide) and out(side) of dolichyl phosphate biosynthesis and recycling in the endoplasmic reticulum.. Glycobiology 11(5):61R-70R PMID: 11425794
- 7. Kean EL. 1999. The dolichol pathway in the retina and its involvement in the glycosylation of rhodopsin.. Biochim Biophys Acta 1473(2-3):272-85 PMID: 10594365
- 8. Scher MG et al.. 1984. Brain dolichyl pyrophosphate phosphatase. Solubilization, characterization, and differentiation from dolichyl monophosphate phosphatase activity.. J Biol Chem 259(23):14580-5 PMID: 6094565
